Why VCs fell in love with pharma R&D in 2021
pharmaphorum
APRIL 5, 2022
And the search for a COVID-19 vaccine opened the industry’s eyes to the idea that innovation could happen quickly, and their processes needn’t be sacrosanct. The risk equation changed for things like decentralised clinical trials, with companies that lacked the capacity for these trials falling behind.
52 
Let's personalize your content